Last $39.21 USD
Change Today +3.23 / 8.98%
Volume 411.7K
As of 3:25 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

ocular therapeutix inc (OCUL) Snapshot

Open
$35.97
Previous Close
$35.98
Day High
$40.62
Day Low
$35.24
52 Week High
03/4/15 - $40.62
52 Week Low
07/31/14 - $11.90
Market Cap
836.5M
Average Volume 10 Days
166.2K
EPS TTM
--
Shares Outstanding
21.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OCULAR THERAPEUTIX INC (OCUL)

Related News

No related news articles were found.

ocular therapeutix inc (OCUL) Related Businessweek News

No Related Businessweek News Found

ocular therapeutix inc (OCUL) Details

Ocular Therapeutix, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology for treating eye diseases and conditions. The company offers ReSure Sealant, a synthetic ocular sealant in sealing clear corneal incisions following cataract surgery. Its products also include Dexamethasone Punctum Plug, a drug-eluting punctum plug; Travoprost Punctum Plug or the treatment of glaucoma and ocular hypertension; Moxifloxacin Punctum Plug for the treatment of bacterial conjunctivitis; and posterior segment injections. Ocular Therapeutix, Inc. was founded in 2006 and is headquartered in Bedford, Massachusetts.

52 Employees
Last Reported Date: 07/25/14
Founded in 2006

ocular therapeutix inc (OCUL) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: $254.9K
Chief Operating Officer
Total Annual Compensation: $362.5K
Executive Vice President of Clinical, Regulat...
Total Annual Compensation: $321.5K
Compensation as of Fiscal Year 2013.

ocular therapeutix inc (OCUL) Key Developments

Ocular Therapeutix, Inc. Presents at RBC Capital Markets Healthcare Conference 2015, Feb-24-2015 11:00 AM

Ocular Therapeutix, Inc. Presents at RBC Capital Markets Healthcare Conference 2015, Feb-24-2015 11:00 AM. Venue: The New York Palace Hotel, New York, New York, United States. Speakers: Amarpreet Sawhney, Founder, Chairman, Chief Executive Officer and President.

Ocular Therapeutix, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 10:40 AM

Ocular Therapeutix, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 10:40 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: Amarpreet Sawhney, Founder, Chairman, Chief Executive Officer and President.

Ocular Therapeutix, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 04:30 PM

Ocular Therapeutix, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 04:30 PM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: Brad Smith, Chief Financial Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCUL:US $39.13 USD +3.15

OCUL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OCUL.
View Industry Companies
 

Industry Analysis

OCUL

Industry Average

Valuation OCUL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2,017.5x
Price/Book 11.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2,478.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCULAR THERAPEUTIX INC, please visit www.ocutx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.